SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-006714
Filing Date
2021-01-22
Accepted
2021-01-22 17:01:19
Documents
8
Period of Report
2021-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a21-3691_18k.htm 8-K 42329
2 EX-4.1 a21-3691_1ex4d1.htm EX-4.1 66424
3 EX-10.1 a21-3691_1ex10d1.htm EX-10.1 98925
4 EX-10.2 a21-3691_1ex10d2.htm EX-10.2 74909
5 EX-99.1 a21-3691_1ex99d1.htm EX-99.1 19746
6 EX-99.2 a21-3691_1ex99d2.htm EX-99.2 12696
7 GRAPHIC g36911moi001.jpg GRAPHIC 2866
8 GRAPHIC g36911mmi001.jpg GRAPHIC 3204
  Complete submission text file 0001104659-21-006714.txt   325112
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 21546609
SIC: 2834 Pharmaceutical Preparations